Novartis AG
NVSEF | OTC
$138.10
-$0.28 (-0.20%)
Sep 24, 2026, 10:16 AM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
PE Ratio | 16.24 | 14.12 | 27.30 | 7.74 | 26.47 | 17.53 |
PEG Ratio | -0.72 | 0.11 | -0.39 | 0.04 | 1.37 | -0.42 |
PS Ratio | 3.75 | 4.49 | 3.66 | 3.52 | 4.28 | 4.22 |
PB Ratio | 4.40 | 4.49 | 3.20 | 2.75 | 3.78 | 3.71 |
P/FCF Ratio | 14.05 | 17.91 | 16.42 | 15.37 | 19.31 | 18.09 |
P/OCF Ratio | 11.01 | 14.50 | 13.34 | 12.34 | 15.66 | 15.09 |
OCF/S Ratio | 34.06 | 30.99 | 27.47 | 28.50 | 27.36 | 27.99 |
Debt / Equity Ratio | 0.71 | 0.56 | 0.47 | 0.46 | 0.67 | 0.53 |
Quick Ratio | 0.84 | 0.93 | 1.04 | 1.29 | 0.68 | 0.83 |
Current Ratio | 1.04 | 1.16 | 1.29 | 1.51 | 0.90 | 1.04 |
Asset Turnover | 0.51 | 0.47 | 0.44 | 0.40 | 0.38 | 0.41 |
Interest Coverage | 14.46 | 11.43 | 10.69 | 12.89 | 11.68 | 9.82 |
Return on Equity | 27% | 32% | 12% | 36% | 14% | 21% |
Return on Assets | 12% | 15% | 6% | 18% | 6% | 10% |
Return on Invested Capital | 16% | 11% | 8% | 10% | 8% | 7% |
Dividend Yield | 3.93% | 3.46% | 4.08% | 3.97% | 3.47% | 3.32% |
Payout Ratio | 63.85% | 48.86% | 111.46% | 30.74% | 91.91% | 58.13% |
FCF Payout Ratio | 59.74% | 66.93% | 71.95% | 64.77% | 71.84% | 64.27% |
Gross Profit Margin | 75.20% | 74.24% | 70.12% | 69.99% | 69.70% | 70.37% |
Net Profit Margin | 23.09% | 31.83% | 13.42% | 45.43% | 16.18% | 24.10% |
Pretax Profit Margin | 26.37% | 19.55% | 16.15% | 49.43% | 19.80% | 18.37% |
Operating Profit Margin | 28.12% | 20.94% | 17.75% | 22.11% | 20.35% | 18.67% |
FCF Margin | 26.69% | 25.09% | 22.31% | 22.88% | 22.18% | 23.35% |
EBITDA Margin | 40.05% | 41.83% | 29.35% | 32.47% | 32.42% | 32.08% |
Add to Watchlist
Select watchlists to add or remove NVSEF